Medical Device Market Entry & Regulatory Advisory in Hong Kong
Hong Kong’s Department of Health operates the Medical Device Administrative Control System (MDACS). Its official guidance describes MDACS as a voluntary administrative framework, distinct from universal mandatory product registration.
Discuss Hong Kong Market EntryWhat to consider
for Hong Kong.
MDACS & Local Responsible Persons
Assess whether the device falls within the scope of MDACS listing. Where listing is pursued, review the Local Responsible Person arrangement, designation and documented responsibilities against current Medical Device Division guidance.
Procurement & market access
Assess hospital and customer procurement criteria separately from legal import requirements. Voluntary listing may be commercially relevant to a specific purchaser; verify the current tender or procurement terms rather than assuming a universal requirement.
Importation & post-market monitoring
Review product-specific legislation that may apply alongside MDACS, including rules relevant to radiation-emitting or telecommunications products where applicable. Plan distribution records, adverse-event communication and post-market monitoring.
How AEGIS APAC can support you
We help assess the applicable pathway, coordinate appropriate local representation and connect regulatory planning with importation, distribution and supply-chain readiness. The scope and appointed providers are confirmed for each engagement.
Planning your next move in Hong Kong?
Whether you’re entering your first regional market or reviewing an existing structure, let’s evaluate your next steps.